Tokyo, May 16 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061588) titled 'Effects of the test product on skin condition' on May 15.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Randomized
Blinding - Double blind -all involved are blinded
Control - Placebo
Primary Sponsor:
Institute - EP Mediate Co., Ltd.
Condition:
Condition - Healthy adult
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The effects of the test product on skin condition will be evaluated using a placebo as a control.
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - Use Test Item once daily for 8 consecutive weeks...